FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma

D Milewski, S Shukla, BE Gryder, A Pradhan… - Oncogene, 2021 - nature.com
The PAX3-FOXO1 fusion protein is the key oncogenic driver in fusion positive
rhabdomyosarcoma (FP-RMS), an aggressive soft tissue malignancy with a particularly poor …
被引用次数：22 相关文章

FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma

D Milewski, S Shukla, BE Gryder, A Pradhan… - …, 2021 - pubmed.ncbi.nlm.nih.gov
The PAX3-FOXO1 fusion protein is the key oncogenic driver in fusion positive
rhabdomyosarcoma (FP-RMS), an aggressive soft tissue malignancy with a particularly poor …

FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.

D Milewski, S Shukla, BE Gryder, A Pradhan… - Oncogene, 2021 - go.gale.com
The PAX3-FOXO1 fusion protein is the key oncogenic driver in fusion positive
rhabdomyosarcoma (FP-RMS), an aggressive soft tissue malignancy with a particularly poor …

FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.

D Milewski, S Shukla, BE Gryder, A Pradhan… - Oncogene, 2021 - europepmc.org
The PAX3-FOXO1 fusion protein is the key oncogenic driver in fusion positive
rhabdomyosarcoma (FP-RMS), an aggressive soft tissue malignancy with a particularly poor …
[HTML] nih.gov

[HTML][HTML] FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.

D Milewski, S Shukla, BE Gryder, A Pradhan… - Oncogene, 2021 - ncbi.nlm.nih.gov
The PAX3-FOXO1 fusion protein is the key oncogenic driver in fusion positive
rhabdomyosarcoma (FP-RMS), an aggressive soft tissue malignancy with a particularly poor …
[PDF] academia.edu

[PDF][PDF] FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.

VV Khan, TV Kalin - Oncogene, 2021 - academia.edu
The PAX3-FOXO1 fusion protein is the key oncogenic driver in fusion positive
rhabdomyosarcoma (FP-RMS), an aggressive soft tissue malignancy with a particularly poor …